<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05123456</url>
  </required_header>
  <id_info>
    <org_study_id>2018-A02447-48</org_study_id>
    <nct_id>NCT05123456</nct_id>
  </id_info>
  <brief_title>Risk of Osteoarthritis of the Knee at Least 5 Years After ACL Reconstruction: Comparative Study Between an Isolated ACL Reconstruction and a Reconstruction Combining ACL and ALL</brief_title>
  <official_title>Risk of Osteoarthritis of the Knee at Least 5 Years After ACL Reconstruction: Comparative Study Between an Isolated ACL Reconstruction and a Reconstruction Combining ACL and ALL</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ramsay Générale de Santé</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Clinical Trial Experts Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Private Hospital Jean Mermoz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ramsay Générale de Santé</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to compare, with a minimum follow-up of 5 years, the&#xD;
      prevalence of femoro-tibial osteoarthritis after an isolated ACL ligamentoplasty or after an&#xD;
      ACL ligamentoplasty combining ACL and ALL.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 15, 2020</start_date>
  <completion_date type="Anticipated">December 15, 2021</completion_date>
  <primary_completion_date type="Actual">April 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of the prevalence of femoro-tibial osteoarthritis</measure>
    <time_frame>1 day</time_frame>
    <description>The prevalence of femoro-tibial osteoarthritis will be assessed by the percentage of patients with cartilage damage to the femoro-tibial compartments on a single X-ray of the face compared to 30 °of flexion.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>ACL</condition>
  <condition>Anterior Curciate Ligament</condition>
  <condition>Anterolateral Ligament</condition>
  <condition>Knee Injuries</condition>
  <condition>ALL</condition>
  <arm_group>
    <arm_group_label>Patient operated with isolated ACL knee reconstruction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Patient operated with ACL and ALL knee reconstruction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radiography</intervention_name>
    <description>Comparative X-ray of the single knee at 30 ° flexion.</description>
    <arm_group_label>Patient operated with ACL and ALL knee reconstruction</arm_group_label>
    <arm_group_label>Patient operated with isolated ACL knee reconstruction</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who underwent an isolated Anterior Cruciate Ligament (ACL) reconstruction or&#xD;
             a combined ACL and anterolateral ligament reconstruction (Extra Articular Plasty)&#xD;
             between January 1, 2011 and March 31, 2012.&#xD;
&#xD;
          -  Patients affiliated or beneficiaries of a social security scheme&#xD;
&#xD;
          -  Patients who have given their express consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with pediatric ACL reconstruction technique&#xD;
&#xD;
          -  Patients with a complex associated gesture such as osteotomy or ligamentoplasty other&#xD;
             than extra articular plastic surgery.&#xD;
&#xD;
          -  Contraindication to a radio control (pregnancy)&#xD;
&#xD;
          -  Patient's refusal to participate in the study&#xD;
&#xD;
          -  Protected patients: Adults under guardianship, curatorship or other legal protection,&#xD;
             deprived of their liberty by judicial or administrative decision; Pregnant,&#xD;
             breastfeeding or parturient woman; Hospitalized without consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean-François Oudet</last_name>
    <phone>0683346567</phone>
    <email>jf.oudet@ecten.eu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie-Hélène Barba</last_name>
    <email>mh.barba@ecten.eu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hopital privé Jean Mermoz</name>
      <address>
        <city>Lyon</city>
        <zip>69008</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bertrand SONNERY COTTET, Dr</last_name>
      <phone>+33 (0)4 37 53 00 24</phone>
      <email>sonnerycottet@aol.com</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 9, 2021</study_first_submitted>
  <study_first_submitted_qc>November 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2021</study_first_posted>
  <last_update_submitted>November 9, 2021</last_update_submitted>
  <last_update_submitted_qc>November 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
    <mesh_term>Knee Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

